These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 12712407

  • 1. Inhibition of proliferation of PC3 cells by the branched-chain fatty acid, 12-methyltetradecanoic acid, is associated with inhibition of 5-lipoxygenase.
    Yang P, Collin P, Madden T, Chan D, Sweeney-Gotsch B, McConkey D, Newman RA.
    Prostate; 2003 Jun 01; 55(4):281-91. PubMed ID: 12712407
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of targeted arterial delivery of the branched chain fatty acid 12-methyltetradecanoic acid as a novel therapy for solid tumors.
    Wright KC, Yang P, Van Pelt CS, Hicks ME, Collin P, Newman RA.
    J Exp Ther Oncol; 2005 Jun 01; 5(1):55-68. PubMed ID: 16416602
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
    Matsuyama M, Yoshimura R, Mitsuhashi M, Hase T, Tsuchida K, Takemoto Y, Kawahito Y, Sano H, Nakatani T.
    Int J Oncol; 2004 Apr 01; 24(4):821-7. PubMed ID: 15010818
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells.
    Pidgeon GP, Kandouz M, Meram A, Honn KV.
    Cancer Res; 2002 May 01; 62(9):2721-7. PubMed ID: 11980674
    [Abstract] [Full Text] [Related]

  • 6. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH, Avis I, Vos MD, Martínez A, Treston AM, Mulshine JL.
    Cancer Res; 1999 May 01; 59(9):2223-8. PubMed ID: 10232612
    [Abstract] [Full Text] [Related]

  • 7. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
    Li L, Zhu Z, Joshi B, Porter AT, Tang DG.
    Anticancer Res; 1999 May 01; 19(1A):51-60. PubMed ID: 10226524
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
    Shappell SB, Gupta RA, Manning S, Whitehead R, Boeglin WE, Schneider C, Case T, Price J, Jack GS, Wheeler TM, Matusik RJ, Brash AR, Dubois RN.
    Cancer Res; 2001 Jan 15; 61(2):497-503. PubMed ID: 11212240
    [Abstract] [Full Text] [Related]

  • 10. Short-chain fatty acids alter tight junction permeability in intestinal monolayer cells via lipoxygenase activation.
    Ohata A, Usami M, Miyoshi M.
    Nutrition; 2005 Jan 15; 21(7-8):838-47. PubMed ID: 15975492
    [Abstract] [Full Text] [Related]

  • 11. The effects of TNF-alpha and inhibitors of arachidonic acid metabolism on human colon HT-29 cells depend on differentiation status.
    Kovaríková M, Hofmanová J, Soucek K, Kozubík A.
    Differentiation; 2004 Feb 15; 72(1):23-31. PubMed ID: 15008823
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effect of exogenous arachidonic acid on alveolar macrophage 5-lipoxygenase metabolism. Role of ATP depletion.
    Peters-Golden M, Shelly C.
    J Immunol; 1988 Mar 15; 140(6):1958-66. PubMed ID: 3126237
    [Abstract] [Full Text] [Related]

  • 13. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.
    Ye YN, Wu WK, Shin VY, Bruce IC, Wong BC, Cho CH.
    Carcinogenesis; 2005 Apr 15; 26(4):827-34. PubMed ID: 15637091
    [Abstract] [Full Text] [Related]

  • 14. Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein.
    Davoodpour P, Landström M, Welsh M.
    BMC Cancer; 2007 Aug 15; 7():161. PubMed ID: 17697368
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of 5-lipoxygenase pathway suppresses the growth of bladder cancer cells.
    Hayashi T, Nishiyama K, Shirahama T.
    Int J Urol; 2006 Aug 15; 13(8):1086-91. PubMed ID: 16903934
    [Abstract] [Full Text] [Related]

  • 16. Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade.
    Tavolari S, Bonafè M, Marini M, Ferreri C, Bartolini G, Brighenti E, Manara S, Tomasi V, Laufer S, Guarnieri T.
    Carcinogenesis; 2008 Feb 15; 29(2):371-80. PubMed ID: 18033773
    [Abstract] [Full Text] [Related]

  • 17. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention.
    Hoque A, Lippman SM, Wu TT, Xu Y, Liang ZD, Swisher S, Zhang H, Cao L, Ajani JA, Xu XC.
    Carcinogenesis; 2005 Apr 15; 26(4):785-91. PubMed ID: 15661803
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effects of digitalis on the proliferation of androgen dependent and independent prostate cancer cells.
    Yeh JY, Huang WJ, Kan SF, Wang PS.
    J Urol; 2001 Nov 15; 166(5):1937-42. PubMed ID: 11586264
    [Abstract] [Full Text] [Related]

  • 19. Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells.
    Ding XZ, Kuszynski CA, El-Metwally TH, Adrian TE.
    Biochem Biophys Res Commun; 1999 Dec 20; 266(2):392-9. PubMed ID: 10600514
    [Abstract] [Full Text] [Related]

  • 20. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
    Yu HP, Shi LY, Lu WH, Su YH, Li YY, Xu SQ.
    J Gastroenterol Hepatol; 2004 Jun 20; 19(6):638-42. PubMed ID: 15151617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.